spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

New research calls for pathology services to be better funded and prioritised

MindMetre Research

Research report from MindMetre presents evidence of the high value offered by pathology services, and suggests that current efficiency savings plans be reviewed

A new report from independent research organisation MindMetre has summarised the evidence for return-on-investment from pathology services in the NHS and questioned any urgent pressure to consolidate pathology laboratories - within and between NHS trusts.

The MindMetre report, which reviewed the range of existing evidence and also canvassed views among a sample of 30 laboratory managers and principal biochemists in England and Wales, was conducted in response Lord Carter’s latest report, Operational productivity and performance in English NHS acute hospitals: Unwarranted variations (February 2016).

The Carter report notes that, “If benchmarks for pathology are unlikely to be achieved [by the deadline of April 2017], trusts should have agreed plans for consolidation and outsourcing to, other providers by January 2017.” The MindMetre review and research cautions against such a tight deadline being imposed, arguing that merger planning is not a substitute for within-laboratory efficiency and improvement drives.

The MindMetre review suggests that a mandatory pathway is set for laboratory productivity improvement (particularly turnaround time reduction), recognising that all aspects of the NHS have to deliver efficiency savings in the current policy environment. However, the review also suggests that the high value offered by pathology services be re-appraised at the strategic level to determine their position in the NHS service funding priorities.

Evidence covered in the review suggests that the immediate and knock-on effects of pathology service capacity and efficiency/productivity are more considerable than service funding would suggest, and could make an even more disproportionately positive contribution to patient outcomes, rapid diagnosis and the avoidance of unnecessary interventions and chronic condition development further down the line.

Paul Lindsell, Mind Metre Managing Director, comments: “A knee-jerk push to consolidate pathology labs is not an easy universal panacea. There is evidently significant headroom for efficiency and productivity gains in pathology workflows and emerging technology. Our report recognises frustrations that greater productivity gains have not yet been achieved. However, we also suggest that the through-the-line benefits that pathology services offer mean it would be a mistake to potentially squeeze such resources in the NHS. In fact, there may be a rationale to put greater resources into pathology services, so long as they are strictly pegged to productivity improvements.”
email info@mindmetre.com
web www.mindmetreresearch.com/
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Gyros Protein Technologies Appoints Frank Witney as Chairman

Automated nanoliter-scale immunoassays company today announced the appointment of a new Chairman of the Board
More info >>


White Papers

Case Study: Precision Pen Injector™

SHL Group

The Precision Pen Injector (PPI™) is an injector originally designed to deliver small yet highly precise doses of Restylane® Skinbooster™, a treatment produced by Swedish biomedical firm Q-Med AB (now Galderma) for revitalizing the skin. This innovative device received praises from doctors and clinicians alike for its ease-of-use and compact design at the 2009 IMCAS (International Master Course on Aging Skin), where the product was first officially launched. Furthermore, the PPI™ was recognized with the prestigious red dot design award for product design.
More info >>

Industry Events

Pharmaceutical Microbiology East Coast

13-14 November 2017, Renaissance Woodbridge Hotel, New Jersey

Drawing on from the huge success of SMi’s Pharmaceutical Microbiology event series, SMi is delighted to announce the launch of Pharmaceutical Microbiology East Coast. Being the eighth in its series, this event will take place in New Jersey, USA, on November 13th and 14th 2017. Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology East Coast 2017 will address the best practices for rapid microbial and sterility testing and tackle the challenges of contamination control.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement